Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients

Infection Control and Hospital Epidemiology

Volumn 17, Issue 12, 1996, Pages 793-797

  Kluytmans, Jan A J W ^a,b   Manders, Marie Jose ^a   Van Bommel, Erik ^a   Verbrugh, Henri ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Ignatius Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PSEUDOMONIC ACID;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HETEROZYGOTE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MALE; MICROBIOLOGY; MIDDLE AGED; NOSE MUCOSA; OINTMENT; RENAL REPLACEMENT THERAPY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADMINISTRATION, INTRANASAL; ANTI-BACTERIAL AGENTS; CARRIER STATE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUPIROCIN; NASAL MUCOSA; OINTMENTS; RENAL DIALYSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0030347308     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141172     Document Type: Article

References (23)

1. Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. N Engl J Med 1986;315:91-96.
2. Bradley JR, Evans DB, Calne RY. Long-term survival in haemodialysis patients. Lancet 1987;I:295-296.
3. Kaplowitz LG, Comstock JA, Landwehr DM, Dalton HP, Mayhall CG. Prospective study on microbial colonization of the nose and skin and infection of the vascular access site in hemodialysis patients. J Clin Microbiol 1988;26:1257-1262.
4. Chow JW, Yu VL. Staphylococcus aureus nasal carriage in hemodialysis patients. Arch Intern Med 1989;149:1258-1262.
5. Goldblum SE, Reed WP, Ulrich JA, Goldman RS. Staphylococcal carriage and infections in hemodialysis patients. Nephrol Dial Transplant 1978;7:1140-1148.
6. Fekety FR Jr. The epidemiology and prevention of Staphylococcal infection. Medicine 1964;43:593.
7. Aly R, Shinefield HR, Litz C, Maibach HI. Role of teichoic acid in the binding of Staphylococcus aureus to nasal epithelial cells. J Infect Dis 1980;141:463-465.
8. Berman DS, Schaefler S, Simberkoff MS. Staphylococcus aureus colonization in intravenous drug abusers, dialysis patients, and diabetes. J Infect Dis 1978;155:829-831.
9. Tuazon CU, Perez A, Kishaba T, Sheagren JN. Staphylococcus aureus among insulin-injecting diabetic patients. An increased carriage rate. JAMA 1975;231:1272.
10. Kirmani N, Tuazon CU, Murray HW, Parrish AE, Sheagren JN. Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis. Arch Intern Med 1978;138:1657-1659.
11. Tuazon CU, Sheagren JN. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis 1974;129:725.
12. Weinstein HJ. The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications. N Engl J Med 1959;260:1303-1308.
13. Luzar MA, Coles GA, Faller B, et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990;322:505-509.
14. Boelaert JR, DeSmedt RA, De Baere YA, et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in hemodialysis patients. Nephrol Dial Transplant 1989;4:278-281.
15. Holton DL, Nicolle LE, Diley D, Bernstein K. Efficacy of mupirocin nasal ointment in eradicating Staphylococcus aureus nasal carriage in chronic hemodialysis patients. J Hosp Infect 1991;17:133-137.
16. Bulanda M, Gruszka M, Heczko B. Effect of mupirocin on nasal carriage of Staphylococcus aureus. J Hosp Infect 1989;14:117-124.
17. Doebbeling BN, Breneman DL, Neu HC, et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment Clin Infect Dis 1993;17:466-474.
18. Reagan DR, Doebbeling BN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment Ann Intern Med 1991;114:101-106.
19. Gilbart J, Perry CR, Slocombe B. High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-TRNA synthetases. Antimicrob Agents Chemother 1993;37:32-38.
20. Barrett SP. The value of nasal mupirocin in containing an outbreak of methicillin-resistant 5 aureus in an orthopaedic unit. J Hosp Infect 1990;15:137-142.
21. Voss A, Milatovic D, Wallrauch-Schwartz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994;13:50-55.
22. Kauffman CA, Terpenning MS, He X, et al. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term care facility with the use of mupirocin ointment. Am J Med 1993;94:371-378.
23. Wenzel RP. Preoperative antibiotic prophylaxis. N Engl J Med 1992;326:337-339.